STUDY TO EVALUATE THE EFFECT AND SAFETY OF AN AYURVEDIC DRUG (URAL CAPSULE) IN RENAL STONES
Phase 2
- Conditions
- Health Condition 1: null- Patients suffering from Stones in Kidney, Ureters and Urinary Bladder
- Registration Number
- CTRI/2018/07/014706
- Lead Sponsor
- ational Institute of Ayurveda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
(1) Patients of both sexes in the age group of 18 to 60 years will be selected for the present study.
(2) Patients who willing to sign written consent and comply with the study procedure.
(3) Patients having stone in kidney / ureter / bladder (KUB) greater than 5 mm but < 12 mm in size
Exclusion Criteria
(1) Patients below 18 years and above 60 years
(2) Patients having uretero-hydronephrosis, diabetes, ulcer disease, history of hypersensitivity to herbal formulation
(3) Patients suffering from serious systemic disorders
(4) Patients with severe complication and requiring immediate surgery
(5) Pregnant or lactating women
(6) Patients who are unwilling to give informed consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy of trial drug on urolithiasisTimepoint: 3 months clinical trial and 2 months follow up
- Secondary Outcome Measures
Name Time Method Safety of the trial drugTimepoint: During treatment and in follow up